Christine Davis

1.4k total citations
44 papers, 947 citations indexed

About

Christine Davis is a scholar working on Epidemiology, Physiology and Molecular Biology. According to data from OpenAlex, Christine Davis has authored 44 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Physiology and 9 papers in Molecular Biology. Recurrent topics in Christine Davis's work include Telomeres, Telomerase, and Senescence (10 papers), Substance Abuse Treatment and Outcomes (10 papers) and Behavioral Health and Interventions (5 papers). Christine Davis is often cited by papers focused on Telomeres, Telomerase, and Senescence (10 papers), Substance Abuse Treatment and Outcomes (10 papers) and Behavioral Health and Interventions (5 papers). Christine Davis collaborates with scholars based in United States, United Kingdom and Canada. Christine Davis's co-authors include Stephen A. Maisto, Patrick R. Clifford, Patrick R. Clifford, Robert N. Baldassano, Kevin A. Hommel, Robert L. Stout, Mindy Engle‐Friedman, Catherine Phillips, Suzanne Riela and Margaret I. Fitch and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and European Heart Journal.

In The Last Decade

Christine Davis

42 papers receiving 909 citations

Peers

Christine Davis
Gemma Hammerton United Kingdom
Sean Harrison United Kingdom
Paul J. Rowan United States
Emily C. Martin United States
Kathleen M. Grant United States
Gemma Hammerton United Kingdom
Christine Davis
Citations per year, relative to Christine Davis Christine Davis (= 1×) peers Gemma Hammerton

Countries citing papers authored by Christine Davis

Since Specialization
Citations

This map shows the geographic impact of Christine Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Davis more than expected).

Fields of papers citing papers by Christine Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Davis. The network helps show where Christine Davis may publish in the future.

Co-authorship network of co-authors of Christine Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Davis. A scholar is included among the top collaborators of Christine Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Davis. Christine Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Graham, Mindy K., Beisi Xu, Christine Davis, et al.. (2024). The TERT Promoter is Polycomb-Repressed in Neuroblastoma Cells with Long Telomeres. Cancer Research Communications. 4(6). 1533–1547. 3 indexed citations
2.
Whitney, Ellen A. Spotts, et al.. (2023). O-078 Mosaic embryos – are they accurately detected by PGT-A?. Human Reproduction. 38(Supplement_1). 1 indexed citations
3.
Murali, Bhavna, Linda Yang, Song Li, et al.. (2022). Treatment of HR+/HER2− breast cancer in urban mainland China: results from the CancerMPact Survey 2019. Breast Cancer Research and Treatment. 195(3). 441–451. 1 indexed citations
4.
Murali, Bhavna, Song Li, Linda Zhao, et al.. (2021). Treatment patterns in non-small-cell lung cancer in China: Results from the CancerMPact survey 2020. Cancer Treatment and Research Communications. 29. 100462–100462. 6 indexed citations
5.
Brosnan‐Cashman, Jacqueline A., Christine Davis, Bill H. Diplas, et al.. (2021). SMARCAL1 loss and alternative lengthening of telomeres (ALT) are enriched in giant cell glioblastoma. Modern Pathology. 34(10). 1810–1819. 11 indexed citations
6.
Moreira, Eloisa De Sá, David S. Robinson, Linda Zhao, et al.. (2021). Patterns of Care and Outcomes for Non-Metastatic Prostate Cancer in the United States: Results of the CancerMPact® Survey 2018. Cancer Management and Research. Volume 13. 9127–9137. 4 indexed citations
7.
Joshu, Corinne E., Christopher M. Heaphy, John R. Barber, et al.. (2020). Obesity is Associated with Shorter Telomere Length in Prostate Stromal Cells in Men with Aggressive Prostate Cancer. Cancer Prevention Research. 14(4). 463–470. 4 indexed citations
8.
Heaphy, Christopher M., Corinne E. Joshu, John R. Barber, et al.. (2020). Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes. Cancer Epidemiology Biomarkers & Prevention. 29(3). 676–680. 11 indexed citations
9.
Heaphy, Christopher M., Michael C. Haffner, Mindy K. Graham, et al.. (2020). Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate. Human Pathology. 101. 70–79. 4 indexed citations
10.
Heaphy, Christopher M., Wenya Linda Bi, Shannon Coy, et al.. (2020). Telomere length alterations and ATRX/DAXX loss in pituitary adenomas. Modern Pathology. 33(8). 1475–1481. 16 indexed citations
11.
Zhao, Linda, et al.. (2020). <p>Treatment of Advanced/Metastatic Melanoma in the United States and Western Europe: Results of the CancerMPact Survey</p>. Cancer Management and Research. Volume 12. 5633–5639. 3 indexed citations
12.
Graham, Mindy K., Jacqueline A. Brosnan‐Cashman, Anthony Rizzo, et al.. (2019). Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells. Molecular Cancer Research. 17(12). 2480–2491. 22 indexed citations
13.
Davis, Christine & Patrick R. Clifford. (2016). Ascertaining the relationships between the trajectories of specific categories of alcohol-related negative consequences and subsequent drinking behavior.. Psychology of Addictive Behaviors. 30(6). 648–658. 4 indexed citations
14.
Zhu, Guangjing, Zhi Liu, Jonathan I. Epstein, et al.. (2015). A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype. Cancer Epidemiology Biomarkers & Prevention. 24(12). 1864–1872. 13 indexed citations
16.
Clifford, Patrick R. & Christine Davis. (2012). Alcohol treatment research assessment exposure: A critical review of the literature.. Psychology of Addictive Behaviors. 26(4). 773–781. 30 indexed citations
17.
Udo, Tomoko, Patrick R. Clifford, Christine Davis, & Stephen A. Maisto. (2009). Alcohol Use Post AUD Treatment Initiation as a Predictor of Later Functioning. The American Journal of Drug and Alcohol Abuse. 35(3). 128–132. 14 indexed citations
18.
Atochina‐Vasserman, Elena N., Andrew J. Gow, James M. Beck, et al.. (2004). Delayed Clearance ofPneumocystis cariniiInfection, Increased Inflammation, and Altered Nitric Oxide Metabolism in Lungs of Surfactant Protein–D Knockout Mice. The Journal of Infectious Diseases. 189(8). 1528–1539. 60 indexed citations
19.
Engle‐Friedman, Mindy, et al.. (2003). The effect of sleep loss on next day effort. Journal of Sleep Research. 12(2). 113–124. 106 indexed citations
20.
Davis, Christine & David C. Fenimore. (1978). The placental transfer and materno-fetal disposition of methadone in monkeys.. Journal of Pharmacology and Experimental Therapeutics. 205(3). 577–586. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026